Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CV
CV logo

CV News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CV News

Health Care Stocks Rise as NYSE Health Care Index Gains 0.2%

Dec 30 2025Yahoo Finance

OceanFirst Financial Corp. Announces $579 Million All-Stock Acquisition of Flushing, Shares Drop 7.4%

Dec 30 2025Benzinga

CapsoVision Inc. Submits FDA 510(k) Application, Shares Surge 8.4%

Dec 30 2025Benzinga

CapsoVision Submits 510(k) for AI-Assisted CapsoCam Plus to Enhance Small Bowel Diagnostics

Dec 30 2025NASDAQ.COM

TEN Holdings Inc. Raises $2.25M in Private Placement, Shares Surge 17%

Dec 30 2025Benzinga

CapsoVision Submits 510(k) Application for AI-Enhanced CapsoCam Plus® to Improve Pathology Detection

Dec 29 2025Globenewswire

CapsoVision Submits 510(k) for AI-Enhanced CapsoCam Plus, Aiming to Improve Pathology Detection

Dec 29 2025Newsfilter

Ultragenyx Shares Plunge 42% Following Phase 3 Study Failures for Setrusumab

Dec 29 2025Benzinga

CV Events

12/29 16:10
CapsoVision Submits FDA 510(k) Application for CapsoCam Plus
CapsoVision announced submission of its 510(k) application to the FDA for its proprietary AI-assisted module for CapsoCam Plus. The company intends for U.S. commercialization activities to commence after the FDA clearance.
12/19 16:00
CapsoVision Inc Trading Halted Due to Volatility
CapsoVision Inc trading halted, volatility trading pause

CV Monitor News

CapsoVision Inc Surges Following Leadership Change

Dec 11 2025

CV Earnings Analysis

No Data

No Data

People Also Watch